Brief: Noxopharm Says New Data Confirms Cancer-Fighting Potential
26/05/2026 03:01
May 26 (Reuters) - Noxopharm Ltd NOX.AX: NEW DATA CONFIRMS CANCER-FIGHTING POTENTIAL DATA SHOWING SOFRA™ TECHNOLOGY PLATFORM WILL BE LEVERAGED TO FIGHT CANCER Further company coverage: NOX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Noxopharm
See all newsAustralia's Noxopharm hits three-month low on discounted placement
Brief: Noxopharm Receives Commitments For Placement
Brief: Noxopharm Requests Trading Halt Pending Material Capital Raising Announcement
Brief: Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness
Australia's Noxopharm rises as novel cancer therapy shows potential